Literature DB >> 16729250

Iron and the folate-vitamin B12-methylation pathway in multiple sclerosis.

S J van Rensburg1, M J Kotze, D Hon, P Haug, J Kuyler, M Hendricks, J Botha, F C V Potocnik, T Matsha, R T Erasmus.   

Abstract

UNLABELLED: Some subjects with multiple sclerosis (MS) present with low blood iron parameters. Anecdotal reports and a single patient study suggest that iron supplementation may be beneficial in these subjects. Myelin is regenerated continually, but prerequisites for this process are iron and a functional folate-vitamin B12-methylation pathway. The aim of this study was to determine iron status, folate and homocysteine in MS subjects, and to evaluate the effect on MS symptoms if deficiencies were addressed.
RESULTS: In relapsing-remitting MS subjects, serum iron concentration correlated significantly with age at diagnosis (r=0.49; p=0.008). In Caucasian female MS subjects, serum iron and ferritin concentrations were significantly lower than in matched controls. In a 6-month pilot study, 12 subjects taking a regimen of nutritional supplements designed to promote myelin regeneration, improved significantly neurologically as measured by the Kurzke EDSS (Total Score means 3.50 to 2.45, 29.9%; p=0.021). These were significantly improved (p=0.002) compared to 6 control group patients taking multivitamins (Kurzke Score increased by 13.9% from 4.83 to 5.50). Both groups had significantly reduced homocysteine concentrations at 6 months, suggesting that methylation is necessary but not sufficient for myelin regeneration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16729250     DOI: 10.1007/s11011-006-9019-0

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  41 in total

1.  Interrelation of vitamin B12 and iron.

Authors:  E V COX; M J MEYNELL; R GADDIE; W T COOKE
Journal:  Lancet       Date:  1959-12-05       Impact factor: 79.321

2.  Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion.

Authors:  Michael H Barnett; John W Prineas
Journal:  Ann Neurol       Date:  2004-04       Impact factor: 10.422

3.  1alpha,25-Dihydroxyvitamin D3 is a potent suppressor of interferon gamma-mediated macrophage activation.

Authors:  Laura Helming; Jens Böse; Jan Ehrchen; Stefanie Schiebe; Thomas Frahm; Robert Geffers; Michael Probst-Kepper; Rudi Balling; Andreas Lengeling
Journal:  Blood       Date:  2005-08-23       Impact factor: 22.113

4.  Oxidative stress in patients with multiple sclerosis.

Authors:  C Syburra; S Passi
Journal:  Ukr Biokhim Zh (1999)       Date:  1999 May-Jun

5.  Iron-deficient mice fail to develop autoimmune encephalomyelitis.

Authors:  Sharon M Grant; Jason A Wiesinger; John L Beard; Margherita T Cantorna
Journal:  J Nutr       Date:  2003-08       Impact factor: 4.798

6.  Mercury and multiple sclerosis.

Authors:  J Clausen
Journal:  Acta Neurol Scand       Date:  1993-06       Impact factor: 3.209

7.  Evidence for increased lipid peroxidation in multiple sclerosis.

Authors:  P K Toshniwal; E J Zarling
Journal:  Neurochem Res       Date:  1992-02       Impact factor: 3.996

8.  Erythrocyte glutathione perioxidase deficiency in multiple sclerosis.

Authors:  V K Shukla; G E Jensen; J Clausen
Journal:  Acta Neurol Scand       Date:  1977-12       Impact factor: 3.209

9.  Effects of low-iron status and deficiency of essential fatty acids on some biochemical constituents of rat brain.

Authors:  O B Oloyede; A T Folayan; A A Odutuga
Journal:  Biochem Int       Date:  1992-08

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  13 in total

1.  Multiple sclerosis-like diagnosis as a complication of previously treated malaria in an iron and vitamin D deficient Nigerian patient.

Authors:  Susan J van Rensburg; Ronald van Toorn; Kelebogile E Moremi; Armand V Peeters; Adesola Oguniyi; Maritha J Kotze
Journal:  Metab Brain Dis       Date:  2016-01-08       Impact factor: 3.584

2.  The fat mass and obesity-associated FTO rs9939609 polymorphism is associated with elevated homocysteine levels in patients with multiple sclerosis screened for vascular risk factors.

Authors:  Wiliam Davis; Susan J van Rensburg; Frans J Cronje; Lindiwe Whati; Leslie R Fisher; Lize van der Merwe; Dieter Geiger; M Shafick Hassan; Tandi Matsha; Rajiv T Erasmus; Maritha J Kotze
Journal:  Metab Brain Dis       Date:  2014-02-18       Impact factor: 3.584

Review 3.  Pathology-supported genetic testing as a method for disability prevention in multiple sclerosis (MS). Part II. Insights from two MS cases.

Authors:  Susan J van Rensburg; Coenraad Hattingh; Clint Johannes; Kelebogile E Moremi; Armand V Peeters; Carel J van Heerden; Rajiv T Erasmus; Annalise E Zemlin; Merlisa C Kemp; Mariaan Jaftha; Aye Aye Khine; Felix C V Potocnik; Lindiwe Whati; Penelope Engel-Hills; Ronald van Toorn; Maritha J Kotze
Journal:  Metab Brain Dis       Date:  2021-03-12       Impact factor: 3.584

Review 4.  Pathology-supported genetic testing as a method for disability prevention in multiple sclerosis (MS). Part I. Targeting a metabolic model rather than autoimmunity.

Authors:  Susan J van Rensburg; Ronald van Toorn; Rajiv T Erasmus; Coenraad Hattingh; Clint Johannes; Kelebogile E Moremi; Merlisa C Kemp; Penelope Engel-Hills; Maritha J Kotze
Journal:  Metab Brain Dis       Date:  2021-04-28       Impact factor: 3.584

Review 5.  The conundrum of iron in multiple sclerosis--time for an individualised approach.

Authors:  Susan J van Rensburg; Maritha J Kotze; Ronald van Toorn
Journal:  Metab Brain Dis       Date:  2012-03-17       Impact factor: 3.584

6.  Restless legs syndrome presenting as an acute exacerbation of multiple sclerosis.

Authors:  James H Bernheimer
Journal:  Mult Scler Int       Date:  2011-07-05

7.  Dietary interventions for multiple sclerosis-related outcomes.

Authors:  Natalie E Parks; Caitlin S Jackson-Tarlton; Laura Vacchi; Roah Merdad; Bradley C Johnston
Journal:  Cochrane Database Syst Rev       Date:  2020-05-19

Review 8.  Nutritional and ecological perspectives of the interrelationships between diet and the gut microbiome in multiple sclerosis: Insights from marmosets.

Authors:  Maria Elisa Perez-Muñoz; Scott Sugden; Hermie J M Harmsen; Bert A 't Hart; Jon D Laman; Jens Walter
Journal:  iScience       Date:  2021-06-10

9.  Transcriptomic profile reveals gender-specific molecular mechanisms driving multiple sclerosis progression.

Authors:  Haritz Irizar; Maider Muñoz-Culla; Lucia Sepúlveda; Matías Sáenz-Cuesta; Álvaro Prada; Tamara Castillo-Triviño; Gorka Zamora-López; Adolfo López de Munain; Javier Olascoaga; David Otaegui
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

10.  Pathogenic Mechanisms Underlying Iron Deficiency and Iron Overload: New Insights for Clinical Application.

Authors:  M J Kotze; D P van Velden; S J van Rensburg; R Erasmus
Journal:  EJIFCC       Date:  2009-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.